Colleen Hoke
CEO / Co-founder

ObjectiveHealth operates a data analytics and machine learning platform that enhances clinical decision-making by extracting actionable insights from real-world evidence. The platform targets inefficiencies in healthcare delivery, aiming to improve patient outcomes through informed treatment strategies.
Raised to date
$21.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CEO / Co-founder
Clinical trials often struggle with patient enrollment and retention, leading to delays and increased costs for pharmaceutical sponsors. Traditional methods of identifying and engaging patients for clinical trials are inefficient and may not reach diverse populations.
ObjectiveHealth offers a technology platform that integrates directly into electronic health records (EHRs) to identify and engage suitable patients for clinical trials. By applying health algorithms to EHR data, the platform optimizes patient matching, streamlines the enrollment process, and improves patient retention rates. This approach provides pharmaceutical sponsors with access to a technologically advanced research network, while also offering physicians the opportunity to seamlessly integrate clinical trials into their practice and provide patients with access to advanced care options within their communities. The platform's integrated approach supports better disease management and improved overall health outcomes.
ObjectiveHealth primarily serves pharmaceutical sponsors seeking to improve clinical trial efficiency, physicians looking to integrate research into their practice, and community health centers aiming to expand care options for their patients.